Virtual reality exposure therapy advances and potential for clinical and experimental use
Neuropsychopharmacology · 2025-01 · 50 (1) · 343-344
DOI: 10.1038/s41386-024-01930-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology, online erschienen am 17.07.2024. Verfasst von Barbara O Rothbaum und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, USA. brothba@emory.edu. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, USA. brothba@emory.edu.
- Division of Chemistry & Chemical Engineering, California Institute of Technology, Pasadena, USA.
Zitieren
APA
Rothbaum, B. O., & Rothbaum, J. O. (2025). Virtual reality exposure therapy advances and potential for clinical and experimental use. Neuropsychopharmacology, 50(1), 343-344. https://doi.org/10.1038/s41386-024-01930-2
Vancouver
Rothbaum BO, Rothbaum JO. Virtual reality exposure therapy advances and potential for clinical and experimental use. Neuropsychopharmacology. 2025;50(1):343-344. doi:10.1038/s41386-024-01930-2
BibTeX
@article{Rothbaum2025,
author = {Rothbaum, Barbara O and Rothbaum, Jacob O},
title = {Virtual reality exposure therapy advances and potential for clinical and experimental use},
journal = {Neuropsychopharmacology},
year = {2025},
volume = {50},
number = {1},
pages = {343--344},
doi = {10.1038/s41386-024-01930-2}
}
EUVIMED